SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Shionogi & Co., Ltd. SGIOY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • JP • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Shionogi & Co., Ltd. (SGIOY) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $10.40. It has a SharesGrow Score of 92/100, indicating a strong investment profile with 6 out of 7 criteria passed.

Financials: revenue is $438.3B, +10%/yr average growth. Net income is $170.4B, growing at +18.3%/yr. Net profit margin is 38.9% (strong). Gross margin is 84.5% (+3.2 pp trend).

Balance sheet: total debt is $21.9B against $1.4T equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 6.63 (strong liquidity). Debt-to-assets is 1.4%. Total assets: $1.5T.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 80/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 88/100 (Pass), Future ?/100 (Fail), Income 100/100 (Pass).

SGIOY SharesGrow Score Overview

95/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 80/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 88/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 100/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SGIOY

SGIOY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SGIOY: +10%/yr revenue is, +18.3%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SGIOY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SGIOY: Debt-to-Equity (D/E) ratio 0.02 (conservative), Current ratio is 6.63 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SGIOY: Gross margin is 84.5% (+3.2 pp trend), $18B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 88/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

SGIOY: Net profit margin is 38.9%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range7.27-12

Volume1K

Avg Volume (30D)103.53K

Market Cap$17.7B

Beta (1Y)0.08

Dividend Yield$0.0884

Share Statistics

EPS (TTM)100.18

Shares Outstanding$1.7B

IPO Date2015-12-01

Employees4,955

CEOIsao Teshirogi

Financial Highlights & Ratios

Revenue (TTM)$438.27B

Gross Profit$370.26B

EBITDA$230.71B

Net Income$170.43B

Operating Income$159.78B

Total Cash$374.8B

Total Debt$21.88B

Net Debt$-352.91B

Total Assets$1.54T

Price / Earnings (P/E)0.1

Price / Sales (P/S)0.04

Analyst Forecast

Company Info

CountryJP

ExchangeOther OTC

CurrencyUSD

ISINUS8246671098

Price Chart

SGIOY

Shionogi & Co., Ltd. ↗ · Other OTC

Healthcare • Drug Manufacturers - Specialty & Generic

7.27 52WK RANGE 12.00

People Also View

Takeda Pharmaceutical Company Limited

Supernus Pharmaceuticals, Inc.

Prestige Consumer Healthcare Inc.

Deciphera Pharmaceuticals, Inc.

Bausch Health Companies Inc.

Curaleaf Holdings, Inc.

Dynavax Technologies Corporation

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message